Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Daiichi Sankyo patents new phosphate transporter inhibitors

Nov. 12, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

Nymox's NX-1207 fails to achieve efficacy endpoints in phase III BPH trials

Nov. 3, 2014

Relypsa submits NDA to FDA seeking approval of patiromer for hyperkalemia

Oct. 23, 2014

Cardiotrophin-1 granted FDA orphan designation for use in kidney transplantation

Oct. 22, 2014

Fispemifene licensed to Apricus Biosciences

Oct. 21, 2014

Topline results reported from phase IIa study of LPCN-1111

Oct. 14, 2014

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...